{
    "eid": "2-s2.0-84975785856",
    "title": "Clinical experience from Thailand: Noninvasive prenatal testing as screening tests for trisomies 21, 18 and 13 in 4736 pregnancies",
    "cover-date": "2016-03-01",
    "subject-areas": [
        {
            "$": "Genetics (clinical)",
            "@code": "2716"
        },
        {
            "$": "Obstetrics and Gynecology",
            "@code": "2729"
        }
    ],
    "keywords": [],
    "authors": [
        "Saknan Manotaya"
    ],
    "citedby-count": 20,
    "ref-count": 24,
    "ref-list": [
        "Establishing of national birth defects registry in Thailand",
        "Clinical application of massively parallel sequencing-based prenatal noninvasive fetal trisomy test for trisomies 21 and 18 in 11105 pregnancies with mixed risk factors",
        "Isolated sonographic markers for detection of fetal Down syndrome in the second trimester of pregnancy",
        "Experience on triple markers serum screening for Down's syndrome fetus in Hat Yai, Regional Hospital",
        "First trimester down syndrome screening by nuchal translucency in a Thai population",
        "Non-invasive prenatal testing: A review of international implementation and challenges",
        "Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma",
        "Clinical implementation of cell-free DNA-based aneuploidy screening: Perspectives from a national audit",
        "Facts Views Vis Obgyn",
        "From Down syndrome screening to noninvasive prenatal testing: 20 years' experience in Taiwan",
        "Nationwide demonstration project of next-generation sequencing of cell-free DNA in maternal plasma in Japan: 1-year experience",
        "Noninvasive prenatal testing for fetal trisomies in a routinely screened first-trimester population",
        "Non-invasive prenatal testing for trisomies 21, 18 and 13: Clinical experience from 146 958 pregnancies",
        "Non-invasive prenatal chromosomal aneuploidy testing - Clinical experience: 100,000 clinical samples",
        "Cost-effectiveness analysis for triple markers serum screening for Down's syndrome in Thai setting",
        "A survey of the knowledge and attitudes of pregnant Thai women towards Down syndrome screening",
        "Noninvasive prenatal diagnosis of common fetal chromosomal aneuploidies by maternal plasma DNA sequencing",
        "MedCalc: a new computer program for medical statistics",
        "ISUOG consensus statement on the impact of non-invasive prenatal testing (NIPT) on prenatal ultrasound practice",
        "ACMG statement on noninvasive prenatal screening for fetal aneuploidy",
        "NSGC practice guideline: Prenatal screening and diagnostic testing options for chromosome aneuploidy"
    ],
    "affiliation": [
        {
            "affiliation-city": "Shenzhen",
            "affilname": "BGI-Shenzhen",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Ltd.",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Chulalongkorn University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Copenhagen",
            "affilname": "Det Sundhedsvidenskabelige Fakultet",
            "affiliation-country": "Denmark"
        }
    ],
    "funding": []
}